News & Updates

Lenzilumab reduces likelihood of survival without ventilation in COVID-19 patients
Lenzilumab reduces likelihood of survival without ventilation in COVID-19 patients
14 Oct 2021 byAudrey Abella

In hospitalized COVID-19 patients, treatment with the novel GM-CSF* neutralizing monoclonal antibody lenzilumab led to a significant improvement in survival without invasive mechanical ventilation (SWOV), findings from the phase III LIVE-AIR study suggest.

Lenzilumab reduces likelihood of survival without ventilation in COVID-19 patients
14 Oct 2021
SGLT2 inhibitors help ward off asthma
SGLT2 inhibitors help ward off asthma
12 Oct 2021

Patients on sodium-glucose co-transporter (SGLT) 2 inhibitors are less likely to develop asthma compared with those on dipeptidyl peptidase (DPP)-4 inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1RAs), a study has found.

SGLT2 inhibitors help ward off asthma
12 Oct 2021
Households, not schools, major SARS-CoV-2 transmission route among HK children
Households, not schools, major SARS-CoV-2 transmission route among HK children
12 Oct 2021 byNatalia Reoutova

Households, and not schools, are the major route of coronavirus disease 2019 (COVID-19) transmission for those 18 years of age, according to a cross-sectional study of nearly 400 Hong Kong children and youths who contracted COVID-19 in 2020.

Households, not schools, major SARS-CoV-2 transmission route among HK children
12 Oct 2021
Tamibaroterone inhalable dry powder shows broad-spectrum activity against SARS-CoV-2, MERS and H1N1
Tamibaroterone inhalable dry powder shows broad-spectrum activity against SARS-CoV-2, MERS and H1N1
12 Oct 2021
Early convalescent plasma infusion does not prevent COVID-19 progression
Early convalescent plasma infusion does not prevent COVID-19 progression
11 Oct 2021 byRoshini Claire Anthony

An infusion of convalescent plasma, obtained via blood donation from individuals who have recovered from COVID-19, did not prevent disease progression in high-risk outpatients who presented within 7 days of COVID-19 symptom onset, results of the phase III US-based SIREN-C3PO* study showed.

Early convalescent plasma infusion does not prevent COVID-19 progression
11 Oct 2021
Early intubation tied to better survival in COVID-19 patients with ARDS
Early intubation tied to better survival in COVID-19 patients with ARDS
11 Oct 2021